ABSTRACT Several plants are used in folk medicine to treat gastrointestinal disorders. Ananas ananassoides (Baker) L.B. Smith (Family Bromeliaceae) is a medicinal plant commonly used in the central region of Brazil against gastric pain. We evaluated two extracts (methanol [MeOH] and dichloromethane [DCM]) obtained from the leaves of A. ananassoides for their ability to protect the gastric mucosa against injuries caused by necrotizing agents (0.3 M HCl/60% ethanol, absolute ethanol, non-steroidal anti-inflammatory drugs, and pylorus ligation) in mice and rats. The best results were obtained after pretreatment with the DCM extract, whereas the MeOH extract did not show any significant anti-ulcerogenic activity but presented mutagenic action. The mechanism of action of the DCM extract suggested the effective participation of endogenous sulfhydryl group in the gastroprotective action. The data, taken together with the absence of acute toxicity and mutagenicity, indicate the apolar extract, instead of the polar, extract of A. ananassoides as a safe and potential new anti-ulcerogenic drug.
INTRODUCTION U
LCERS RELATED TO Helicobacter pylori infection are becoming scarce. However, peptic ulcers associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) remain a major clinical problem, which has not been solved by introduction of selective inhibitors of cyclooxygenase. 1 In addition, the literature reveals the large variety of chemical compounds isolated from medicinal plants with anti-ulcer activity. 2 Ananas ananassoides is a widespread plant in Cerrado lands popularly known as "abacaxi-do-cerrado," "ananás-de-raposa," and "macambira." Its fruits are used to make juice, wine, and ice cream. 3 In traditional folk medicine, decocted aerial parts of A. ananassoides are used as a treatment for ulcers and gastrointestinal disturbances. 4 Despite the popular use of this species as a medicinal plant, there are no data on its pharmacological and mutagenic effects, phytochemical constituents, or possible toxic property.
Therefore, the present study has been conducted to evaluate the mutagenic activity in Salmonella/microsome assays, using different in vivo experimental models in rodents to evaluate the acute toxicity and anti-ulcer activity of two organic extracts (dichloromethane [DCM] and methanol [MeOH] ) obtained from A. ananassoides leaves.
MATERIALS AND METHODS

Extraction, fractionation, and identification
Leaves of A. ananassoides were collected at Porto Nacional city, in the state of Tocantins, Brazil, by C.A.H.-L. A flowered voucher was identified by Prof. Solange Lolis from the Universidade Federal do Tocantins, Porto Nacional city, and deposited under voucher number 7161 at the Herbário do Tocantins herbarium. Dry leaves (600 g) of A. ananassoides were powdered and macerated with 1 L of DCM or MeOH successively at room temperature (1 week for each solvent). The solutions were filtered through filter paper, and the solvent was evaporated under reduced pressure affording 12 g (2% of the dry weight) of DCM extract and 30 g (5%) of MeOH extract.
An aliquot of DCM extract (3.0 g) was fractionated by silica gel column chromatography eluted with gradient mixtures of hexane/ethyl acetate to produce 100 fractions. These fractions were checked by thin-layer chromatography on sil-ica gel plates using mixtures of hexane/ethyl acetate as eluent and revealed with iodine vapors and/or anisaldehyde/sulfuric acid, which showed that the fractions were divided into 19 groups. Fractions 1 and 8 were purified by successive column chromatography over silica gel, allowing the identification of hydrocarbons and fatty acid ester. Fraction 9 (90 mg) was purified using silica gel column chromatography, leading to the identification of the compounds stigmasterol 1, sitosterol 2, and campesterol 3 ( Fig. 1) by gas chromatography-flame ionization detector (model CP 3380, Varian, Walnut Creek, CA) using standard compounds available from our collection. Purification of fraction 12 (74.0 mg) was achieved by silica gel column chromatography using CHCl 3 /MeOH/H 2 O (80:18:2, by volume) to yield pure the compounds p-coumaric acid 4 and caffeic acid 5 ( Fig. 1) , identified by nuclear magnetic resonance spectroscopy (500 MHz INOVA spectrometer [Varian, Palo Alto, CA], using dimethyl sulfoxide-d 6 as the solvent and trimethylsilane as the internal standard).
A portion (10.0 g) of the MeOH extract of A. ananassoides was partitioned with a mixture of ethyl acetate/H 2 O (1:1, vol/vol). The ethyl acetate fraction (2.8 g) was subjected to gel permeation chromatography on a Sephadex LH-20 (Pharmacia, Uppsala, Sweden) column (70 ϫ 3 cm), eluted with MeOH. We collected 120 fractions (10 mL), which were checked by thin-layer chromatography on silica gel plates eluted with a mixture of CHCl 3 /MeOH/H 2 O (80:18:2, by volume) and revealed with anisaldehyde/sulfuric acid solution. Fractions showing similar thin-layer chromatography data were combined, affording 13 major fractions. Fraction 6 (95.0 mg) was fractionated by successive column chromatography on silica gel (Merck, Whitehouse Station, NJ) eluted with CHCl 3 /MeOH/H 2 O (80:18:2, by volume), furnishing compounds 4 and 5 ( Fig. 1 ) identified by nuclear magnetic resonance spectroscopy (500 MHz IN-OVA spectrometer, using dimethyl sulfoxide-d 6 as the solvent and trimethylsilane as the internal standard).
The H 2 O fraction (7.0 g) was analyzed by nuclear magnetic resonance spectroscopy, which determined that its main components are sugars (mainly glucose and fructose).
Drugs and chemicals
Hydrochloric acid, sodium hydroxide, ethanol (EtOH) (Vetec, S.A., São Paulo, Brazil), Tween 80 (Synth, São Paulo), cimetidine, N G -nitro-L-arginine methyl ester (L-NAME), N-ethylmaleimide (NEM), carbenoxolone, atropine (Sigma Chemical Co., St. Louis, MO), piroxicam (Medley, São Paulo), and charcoal (Chemco, São Paulo) were used in this study. The MeOH extract was dissolved in saline (vehicle), and the DCM extract was dissolved in Tween 80 at 8%. All substances were prepared immediately before use, and the reagents used were of analytical grade. All reagents used to prepare buffers and media were from Merck or Sigma Chemical Co. The S9 fraction from Aroclor 1254-treated rats was obtained from Molecular Toxicology, Inc. (Annapolis, MD).
Animals
All experiments were performed on male Swiss mice (weighing 30 Ϯ 5 g) or male Wistar rats (weighing 280 Ϯ 20 g) obtained from the São Paulo State University Animal House in Botucatu, SP, Brazil. The animals were fed a certified Labina ® (São Paulo) diet with free access to tap water and were housed in a 12-hour light/dark cycle at a temperature of 24 Ϯ 1°C. Fasting was used prior to all assays because both the standard drugs and extracts were always administered orally (by gavage) or intraduodenally using a saline solution (10 mL/kg) or Tween 80 at 8% as the vehicle. The São Paulo State University Institutional Animal Care and Use Committee, following the recommendations of the Canadian Council on Animal Care, 5 approved all of the protocols used.
HCl/EtOH-induced ulcer
The anti-ulcerogenic activity of the MeOH and DCM extracts obtained from A. ananassoides in this model was assessed in mice. 6 Mice were divided into 10 groups (n ϭ 7-8), which were fasted for 24 hours prior to oral dosing with the vehicle (saline or Tween 80 at 8%), lansoprazole (30 mg/kg), or MeOH or DCM extracts (250, 500, or 1,000 mg/kg). Fifty minutes after the treatments, all animals received orally 0.2 mL of a 0.3 M HCl/60% EtOH solution. Animals were killed by cervical dislocation 1 hour after the administration of HCl/EtOH solution; the stomachs were removed, opened along the greater curvature, and fixed between two glass plates. The ulcerative lesion index (ULI) was calculated according to the methodology described by Szelenyi and Thiemer. 7 
ANTI-ULCER AND MUTAGENIC
NSAID-induced gastric ulcers in mice
In this model, 8 gastric ulcer was induced using piroxicam (30 mg/kg, s.c.) administered to mice (n ϭ 4-8). The MeOH or DCM extracts from A. ananassoides (250, 500, or 1,000 mg/kg), cimetidine (100 mg/kg), or vehicle (saline or Tween 80 at 8%) were administered orally 30 minutes before the induction of gastric ulcer. The animals were killed by cervical dislocation 4 hours after treatment with the ulcerogenic agent. The stomachs were removed, and the ulcerative index was calculated as described previously.
EtOH-induced ulcer
After 24 hours of fasting, rats (n ϭ 5-6) received an oral administration of DCM or MeOH extracts from A. ananassoides (250, 500, or 1,000 mg/kg), lansoprazole (30 mg/kg), or vehicle. One hour after treatment, all rats received 1 mL of 99.5% EtOH to induce gastric ulcer. The animals were killed 1 hour after treatment with the ulcerogenic agent, and the stomachs were removed and opened along the greater curvature to determine the lesion damage. 9 
Determination of activity on intestinal motility
The effect of the extract on intestinal motility in mice was tested using the charcoal method. 10 The animals were fasted for 12 hours but were allowed free access to water. They were randomized and placed in five cages with five animals per cage. Groups were pretreated orally with DCM or MeOH extract (250, 500, or 1,000 mg/kg), atropine (5 mg/kg), or vehicle. After 30 minutes, each mouse was administered activated charcoal 10% (10 mL/kg, p.o.). All animals were killed 30 minutes later by cervical dislocation, and the small intestine was rapidly dissected for measurement of the distance traversed by the charcoal meal from the pylorus to the ileocecal junction, expressed as a percentage of the total distance with the values transformed to arcsine for statistical analyses.
EtOH-induced gastric mucosal lesion in L-NAME-pretreated rats
The rats were fasted for 24 hours and were placed randomly into six cages with five animals per cage. The animals were treated with L-NAME (an inhibitor of nitric oxide synthase) (70 mg/kg) or saline intraperitoneally and 30 minutes later received an oral dose of the vehicle, carbenoxolone (100 mg/kg), or DCM extract (500 mg/kg). After 60 minutes, all groups were orally treated with 1 mL of absolute EtOH for gastric ulcer induction. 11 Animals were killed 1 hour after the administration of EtOH by cervical dislocation, and the stomachs were excised; gastric damage was determined as described previously.
Determination of gastric secretion
All groups of mice (n ϭ 10-11) were fasted for 24 hours, with free access to water. Immediately after pylorus ligature, DCM extract from A. ananassoides (500 mg/kg), cimetidine (100 mg/kg) as a positive control, or vehicle was administered intraduodenally. The animals were killed 4 hours later by cervical dislocation; the abdomen was opened, and another ligature was placed around the esophagus close to the diaphragm. The stomachs were removed, and the gastric content was collected to determine the total amount of gastric juice acid (in mL) and pH values. Distilled water was added, and the resultant solution was centrifuged at 3,000 g for 10 minutes. Total acid in the gastric secretion was determined in the supernatant volume by titration to pH 7.0 with 0.01 N NaOH. 12 
EtOH-induced gastric lesions in NEM-pretreated rats
Rats were divided into groups of five animals that were fasted for 24 hours. They had been previously treated intraperitoneally with NEM (10 mg/kg) or saline. Thirty minutes later, the different groups received an oral dose of the vehicle, carbenoxolone (100 mg/kg), or DCM extract (500 mg/kg). After 60 minutes, all groups were orally treated with 1 mL of absolute EtOH for gastric ulcer induction. 13 Animals were killed 1 hour after the administration of EtOH by cervical dislocation, the stomachs were excised, and gastric damage was determined as described previously.
Acute toxicity studies
Control and treated groups consisted of 10 animals each (Swiss male mice). The treated group received DCM extract, whereas the controls received saline by gavage at a single dose of 5,000 mg/kg of animal weight. The animals were observed carefully 30, 60, 120, 240, and 360 minutes after the treatment. The mortality, measured body weight, and behavioral screening were recorded once every 24 hours for 14 days following treatment. The macroscopic analyses and weight of vital organs such as the liver, kidney, heart, and lung were compared to those of animals treated with DCM extract and those receiving the vehicle. 14 Salmonella mutagenicity assay Mutagenicity was tested by the Salmonella/microsome assay, based on the preincubation method, 15 21 .0 mg per plate for strains TA100, TA98, TA97a, and TA102) and DCM extract (1.75, 3.5, 7.0, 10.5, and 14.0 mg per plate for TA98 and TA100 and 0.04, 0.09, 0.17, 0.26, and 0.35 mg per plate for TA102 and TA97a) dissolved in dimethyl sulfoxide were added to 100 L of bacterial culture and 0.5 mL phosphate buffer (pH 7.4) or 0.5 mL of S9 mixture and incubated for 20-30 minutes at 37°C.
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After the incubation, 2 mL of top agar was added, mixed, and then poured onto a plate of minimal agar. The plates were incubated at 37°C for 48 hours, and His ϩ revertant colonies were enumerated with an automatic counter (ProtoCOL, Synbiosis, Cambridge, UK). All experiments were analyzed in triplicate. The concentrations were selected on the basis of a preliminary toxicity test. In all subsequent assays, the upper limit of the dose range tested was either the highest nontoxic dose or the lowest toxic dose determined in this preliminary assay. Toxicity was apparent either as a reduction in the number of His ϩ revertants or as an alteration in the autotrophic background (i.e., background lawn). The statistical analysis was performed with the Salanal computer program. 16 The mutagenic index was also calculated for each dose, as the average number of revertants per plate divided by the average number of revertants per plate in the negative (solvent) control. A sample was considered positive when the mutagenic index was Ն2 for at least one of the tested doses and if it had a reproducible dose-response curve. 17 The standard mutagens used as positive controls in each experiment were 2-aminoanthracene (1.25 g per plate) and sodium azide (1.25 g per plate) for TA100, 4 nitro-ophenylenediamine (10 g per plate) and 2-aminoanthracene (1.25 g per plate) for TA98 and TA97a, and mitomycin C (0.25 g per plate) and 2-aminofluorene (5 g per plate) for TA102. Dimethyl sulfoxide served as the negative (solvent) control.
Statistical analyses
The results are presented as mean Ϯ SE values. One-way analysis of variance (ANOVA) followed by Dunnett's or Fisher's pairwise test was employed for comparing three or more groups. Values of P Ͻ .05 were considered significant.
RESULTS AND DISCUSSION
Natural products research is guided in many cases by ethnopharmacological knowledge and has made substantial contributions to drug innovation by providing novel chemical structures and/or action mechanisms. 18 In Brazil, a large number of herbal extracts are used in folk medicine to treat various types of digestive disorders. 19, 20 A. ananassoides is a medicinal plant commonly used in folk medicine to treat stomachache, but there are no data about its pharmacological action on the gastrointestinal system or its possible toxic and mutagenic effects. Since the ethnopharmacological information about the dosing employed for A. ananassoides was imprecise and because active principles contained in crude extracts are normally found in small amounts, in this work we used a maximum dose of crude extract of 1,000 mg/kg in order to compare its activity with those obtained using the typical doses for commercial drugs such as cimetidine (100 mg/kg), carbenoxolone (100 mg/kg), or lansoprazole (30 mg/kg).
We evaluated the effect of MeOH and DCM extracts obtained from A. ananassoides administered to rodents using the different standard experimental models of induced gastric ulcer. In order to establish a general profile of the antiulcerogenic activity of extracts that would permit us to characterize its mechanism of action, we plotted the dose-response curve using three oral doses of 250, 500, and 1,000 mg/kg, p.o., to select the dose that produces the best effect.
The ability of gastric mucosa to resist injury produced by endogenous secretions (acid, pepsin, and bile) and by ingested irritants (e.g., alcohol) can be attributed to a number of factors that have been collectively referred to as mucosal defense. 1 The formation of gastric mucosal lesions by necrotizing agents such as HCl and EtOH has been reported to involve the depression of these gastric defensive mechanisms. HCl/EtOH-induced gastric ulcers also promote stasis in gastric blood flow that contributes to development of the hemorrhagic and necrotic aspects of tissue injury. 21 In the HCl/EtOH-induced gastric ulcers, the lesions were characterized by multiple hemorrhage red bands of different sizes along the long axis of the glandular stomach. Compared to the control value, administration of lansoprazole and of the DCM extract significantly inhibited ulcerative lesion at all doses, but treatment with the MeOH extract showed significant activity only at the highest dose (Table  1) . EtOH-induced ulcers are not inhibited by antisecretory agents such as cimetidine but are inhibited by agents that enhance mucosal defensive factors such as prostaglandins. 9 Therefore, our results suggest that the DCM extract has an anti-ulcerogenic effect related to cytoprotection. Many isoprenoids, including carbenoxolone and sterols, are known to present anti-ulcer activity, and the hydroxyl group at the C-3 position seems to be a prerequisite for their anti-ulcer activity. 22 In fact, ␤-sitosterol (present in the DCM extract composition) is one of the active steroids of Amphipterygium adstringens (Family Julianaceae) and displayed a moderate gastroprotective activity. 11 NSAIDs such as aspirin, piroxicam, and indomethacin remain among the most commonly used pharmacological agents. 23 However, these classes of substances may cause gastrointestinal ulceration because of the ability of these agents to suppress prostaglandin synthesis. 1 Table 1 indicates a discrete anti-ulcerogenic effect of the MeOH and DCM extracts in the NSAID-induced lesion models, since significant reductions in gastric mucosal damage were achieved only after pretreatment with the highest dose.
Alcohol is an etiological factor closely related to gastric mucosal damage. Intragastric absolute EtOH administration to 24-hour-fasted rats produced linear hemorrhagic lesions, extensive submucosal edema, mucosal friability, inflammatory cells, and epithelial cell loss in the stomach, which are typical characteristics of alcohol injury. 24 The pathogenesis of EtOHinduced gastric mucosal damage is still unknown, but the damage occurs both directly and indirectly through various mediators such as cyclooxygenase, lipoxygenase, cytokines, and oxygen-derived free radicals. 25 EtOH and its metabolites (ac-etaldehyde) promote tumor development by generating free radical (superoxide, peroxide, and hydroxyl), and EtOH is directly cytotoxic and facilitates the development of oropharyngeal, esophageal, gastric, and colon cancer. 26 The best results were obtained using the absolute EtOH model. One hour before induction of the gastric lesion, oral administration of DCM extract significantly decreased the ULI in a dose-dependent manner (Table 1) , with reduction in not only the size but also the severity of the wounds. Promising results were obtained using 500 mg/kg of the crude extract, which led to 94% inhibition. In addition, administration of the MeOH extract did not show any significant activity in this model. The interesting point of this result is that people commonly use the tea form of this medicinal plant against ulcer and gastric pains, which, based on our result, does not represent the best manner to extract anti-ulcer compounds. Accordingly, our study showed that best results were obtained with the DCM extract of A. ananassoides.
The velocity of intestinal travel is one of the factors that affected the intensity of luminal absorption, induced peptic ulcer, and probably regulated the bioavailability of the drug when orally administered. 27 Thus, the gut transit test with activated charcoal was carried out in order to determine the effect of DCM and MeOH extracts from A. ananassoides on intestinal motility. Our data showed that neither extract was able to change the propulsion of charcoal meal in a dose-dependent manner (Table 2) .
Since the most promising results were obtained using the DCM extract, we continued our studies using only a single
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It is well known that nitric oxide is involved in the modulation of gastric mucosal integrity and is important in the regulation of acid, alkaline, and mucus secretion and gastric mucosal blood flow. 28 In order to investigate the role of endogenous nitric oxide in cytoprotection, we used the nitric oxide synthetase inhibitor L-NAME to assess the protective effect of the DCM extract on EtOH-induced gastric hemorrhagic lesions (Table 3) . Pretreatment with L-NAME did not alter the cytoprotection induced by the DCM extract. Oral administration of the DCM extract (500 mg/kg) to L-NAME (70 mg/kg, i.p.)-pretreated animals produced a reduction in gastric hemorrhagic lesions when compared to the L-NAMEpretreated control value. The gastroprotective effect of the DCM extract observed after pretreatment with L-NAME (13.20 Ϯ 3.34 mm) was similar to that presented by pretreatment with saline (17.60 Ϯ 5.47 mm). This result indicates that pretreatment with L-NAME did not alter the DCM extract-induced cytoprotection of EtOH-induced gastric lesions and hence precludes the role of endogenous nitric oxide in mediating the protective effect of the DCM extract from A. ananassoides.
We also evaluated the biochemical changes promoted by the DCM extract in gastric juice parameters of mice subjected to pylorus ligature (Table 4) . Intraduodenal administration of the DCM extract significantly decreased the gastric juice production, similarly to cimetidine. However, the DCM extract did not promote any change in pH or total gastric acid values. Therefore, this result suggests that the DCM extract does not exert an antisecretory effect.
The synthesis of mucus that strengthens the mucosal barrier against harmful agents also has an important function in gastric protection. The continuous adherent mucus layer is also a barrier to luminal pepsin, thereby protecting the underlying mucosa from proteolytic digestion. 29 The adherent mucus gel structure creates an undisturbed layer to support surface neutralization of acid and acts as a protective physical barrier against luminal pepsin. Mucosal subunits are joined by disulfide bridges that, if reduced, render mucus water-soluble. 30 Accordingly, the literature reports that en- dogenous non-protein sulfhydryls are key compounds in mucosal protection against EtOH-induced gastric injury. 31 Usually, the growth in damage is accompanied by a decrease in concentration of mucosal non-protein sulfhydryl compounds, because the SH groups bind the free radicals formed due to the action of noxious agents.
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For this reason, we investigated the possible involvement of endogenous non-protein sulfhydryls in the gastroprotective effect of the DCM extract by pretreating animals with NEM, an SH group blocker, in EtOH-induced gastric lesions ( Table  3) . Pretreatment of animals with NEM markedly increased the gastric lesions when compared to control groups. Animals treated with DCM extract showed a significant reduction in the ULI (98% with saline vs. 37% with NEM). These findings suggest that the increase in endogenous SH groups is involved in the protective effects of the DCM extract. Matsuda et al. 32 suggest that endogenous prostaglandins and sulfhydryl compounds are also involved in the protective effects of phenylpropanoids isolated from rhizomes of Alpinia galanga that were also present in A. ananassoides.
As part of the present pharmacological study, the acute toxicity in mice of the DCM extract obtained from aerial parts of A. ananassoides was then investigated. A single oral administration of DCM extract from A. ananassoides did not produce any visible signs or symptoms of toxicity in the treated animals. After 14 days of administration of DCM extract, no animal died, and no significant macroscopic changes in daily body or organ weight were observed. At autopsy, no significant macroscopic change or lesion was observed in the viscera of any animal (data not shown).
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Statistically different values by ANOVA are indicated: *P Ͻ .05, **P Ͻ .01.
The use of ethnomedicinal information has been contributing to health globally through the isolation of bioactive compounds for direct use in medicine. Therefore, it is imperative to evaluate the mutagenic potential of these compounds. 33 Short-term tests that detect genetic damage have provided information permitting evaluation of the carcinogenic risk of a chemical to humans. 34 The Ames assay, which is recommended for testing the mutagenicity of chemical compounds with potential pharmacological application, 35 was used in the present study that was undertaken to assess the mutagenic effect of A. ananassoides extracts (Table 5) .
When mutagenic activity was evaluated the results obtained showed that the MeOH extract induced a significant increase in the number of mutant revertants in the TA98 and TA100 strains, in the absence of metabolic activation, suggesting the presence in the extract of direct mutagens that induced frameshift-type mutations and base pair substitution. But when the DCM extract was tested, no mutagenic effect was observed (Table 5) . These results are very interesting, since the most promising results in anti-ulcer activity were obtained using the DCM extract. This extract was evaluated by phytochemical analysis, and we detected the presence of hydrocarbons, polyisoprene derivatives, fatty acid esters, steroids (campesterol, stigmasterol, and sitosterol), and phenylpropanoid acids (caffeic acid and its derivatives). The literature reports the chemopreventive action and anti-ulcer effects of caffeic acid and its derivatives, 36 which probably contributed to the absence of both mutagenic activity and gastroprotective effects of the DCM extract of A. ananassoides.
In conclusion, the data obtained demonstrated the gastric anti-ulcer activity of the DCM extract from the aerial parts of A. ananassoides. This effect involves an augmented defense mechanism of the gastrointestinal mucosa against aggressive factors, since we observed a strong participation of SH groups in preventing or attenuating the ulcer process. Our data, taken together with the absence of acute toxicity and mutagenicity of the DCM extract of A. ananassoides, indicate the promising use of this species against gastric disease.
